Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75b30ff8273a54b655e5eb2eed62b4b1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10345 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2007-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43a6d8e54a5dc42f44730e807a62f147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f35593413f3f21f531144e8f3e4a42c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce2d6cb154ce28d40dbb75de7fcab2f1 |
publicationDate |
2008-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008247996-A1 |
titleOfInvention |
Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation |
abstract |
The invention provides methods of treating neoplasia using combinations of target cell-specific replication competent adenoviral vectors and chemotherapy, radiation therapy or combinations thereof. The adenoviral vectors are target cell-specific for the particular type of neoplasia for which treatment is necessary and the combination with the chemotherapy and/or radiation leads to synergistic treatment over existing adenoviral therapy or traditional chemotherapy and radiation therapy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012308521-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077156-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11130968-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011068918-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401529-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654300-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859287-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011301222-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8461126-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722643-B2 |
priorityDate |
2000-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |